FAIRMOUNT FUNDS MANAGEMENT LLC purchased 98.0% of their position (1.36M shares) of CRESCENT BIOPHARMA, INC. on the open market
Open‑market purchase worth $18.24M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/8/2025ACC: 0001104659-25-119320
Director10% Owner
Since Jun 2025
+1.49M
Net shares
Net buyer
$18.24M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1.49M acquired
Non-Derivative Transactions1
Ordinary Shares
Indirect
Shares
+1.36M
Price / share
$13.41
Trade value
$18.24M
% of position
98.0%
12/4/2025
1.39M→2.75M
Total
Net shares
+1.36M
Net value
$18.24M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 12/4/2025 | P · Purchase | +1.36M | $13.41 | $18.24M | 98.0% | 1.39M | 2.75M |
| Total | +1.36M | $18.24M | ||||||
Derivative Transactions1
Pre-Funded Warrant (Right to Buy)
Indirect
Converts to
Ordinary Shares
131.43K shares
Shares
+131.43K
Strike price
0.001
Held after
1.77M
Exercisable
—
12/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-Funded Warrant (Right to Buy) Indirect | Ordinary Shares131.43K shares | 12/4/2025 | P · Purchase | +131.43K | 0.001 | — | 1.77M |